Ledger.Open graph →
SEC Form D · filed April 25, 2019

Sherlock Biosciences, Inc

Offering
$33.8M
Sold
$32.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Rahul Dhanda · Cambridge, MAExec · DirectorDavid Walt · Cambridge, MADirectorJames Collins · Plano, TXDirectorIssi Rozen · Cambridge, MADirectorRahul Dhanda · Cambridge, MAExec · DirectorJames Collins · Cambridge, MADirectorIssi Rozen · Cambridge, MADirectorDavid Walt · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗